We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,278 results
  1. Polyanhydride nanovaccine against H3N2 influenza A virus generates mucosal resident and systemic immunity promoting protection

    Influenza A virus (IAV) causes significant morbidity and mortality worldwide due to seasonal epidemics and periodic pandemics. The antigenic...

    Christopher E. Lopez, Zeb R. Zacharias, ... Kevin L. Legge in npj Vaccines
    Article Open access 31 May 2024
  2. The biological characteristics and infection dynamics of a novel H3N2 canine influenza virus genotype in beagles

    Background

    The canine influenza virus (CIV) outbreak has garnered considerable attention as it poses a significant threat to dog health. During the...

    Fei-fei Ge, Hai-xiao Shen, ... Shixin Huang in Virology Journal
    Article Open access 04 July 2024
  3. Seasonal influenza vaccination expands hemagglutinin-specific antibody breadth to older and future A/H3N2 viruses

    History of influenza A/H3N2 exposure, especially childhood infection, shape antibody responses after influenza vaccination and infection, but have...

    Nina Urke ErtesvƄg, Rebecca Jane Cox, ... Mai-Chi Trieu in npj Vaccines
    Article Open access 24 June 2022
  4. Antigenic drift and immunity gap explain reduction in protective responses against influenza A(H1N1)pdm09 and A(H3N2) viruses during the COVID-19 pandemic: a cross-sectional study of human sera collected in 2019, 2021, 2022, and 2023

    Background

    Non-pharmaceutical interventions implemented during the COVID-19 pandemic resulted in a marked reduction in influenza infections globally....

    Even Fossum, Andreas Rohringer, ... Olav Hungnes in Virology Journal
    Article Open access 06 March 2024
  5. Evaluation of the Effectiveness of Metabolites of Bacterial Strains Bacillus thuringiensis against Human Influenza Virus A/Aichi/2/68 (H3N2) In Vitro and In Vivo

    The morphological and physiological characteristics of Bacillus thuringiensis strains were analyzed and conditions for obtaining culture fluid with...

    I. S. Andreeva, N. A. Mazurkova, ... A. S. Safatov in Bulletin of Experimental Biology and Medicine
    Article 28 September 2020
  6. Phylogenetic analysis of HA and NA genes of influenza A viruses in immunosuppressed inpatients in Bei**g during the 2018ā€“2020 influenza seasons

    Background

    Influenza A viruses have undergone rapid evolution with virulent; however, complete and comprehensive data on gene evolution and amino acid...

    Yafen Liu, Yue Wang, ... Yan Gao in Virology Journal
    Article Open access 26 May 2023
  7. Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial

    Background

    Adjuvanted inactivated influenza vaccine (aIIV) and high-dose inactivated influenza vaccine (HD-IIV) are U.S.-licensed for adults...

    Kenneth E. Schmader, Christine K. Liu, ... Emmanuel B. Walter in Immunity & Ageing
    Article Open access 01 July 2023
  8. Targeting influenza A virus by splicing inhibitor herboxidiene reveals the importance of subtype-specific signatures around splice sites

    Background

    The association between M segment splicing and pathogenicity remains ambiguous in human influenza A viruses. In this study, we aimed to...

    Yi-Ju Han, Kuo-Ming Lee, ... Shin-Ru Shih in Journal of Biomedical Science
    Article Open access 03 February 2023
  9. Transmission and pathogenicity of canine H3N2 influenza virus in dog and guinea pig models

    Background

    Influenza A virus causes respiratory disease in many animal species as well as in humans. Due to the high human-animal interface, the...

    Ratanaporn Tangwangvivat, Supassama Chaiyawong, ... Alongkorn Amonsin in Virology Journal
    Article Open access 12 October 2022
  10. Immunization with matrix-, nucleoprotein and neuraminidase protects against H3N2 influenza challenge in pH1N1 pre-exposed pigs

    There is an urgent need for influenza vaccines providing broader protection that may decrease the need for annual immunization of the human...

    Eleni Vatzia, Katherine Feest, ... Elma Tchilian in npj Vaccines
    Article Open access 15 February 2023
  11. An epitope-optimized human H3N2 influenza vaccine induces broadly protective immunity in mice and ferrets

    There is a crucial need for an improved H3N2 influenza virus vaccine due to low vaccine efficacy rates and increased morbidity and mortality...

    Brianna L. Bullard, Jennifer DeBeauchamp, ... Eric A. Weaver in npj Vaccines
    Article Open access 23 June 2022
  12. A polyvalent virosomal influenza vaccine induces broad cellular and humoral immunity in pigs

    Background

    Influenza A virus (IAV) is endemic in pigs globally and co-circulation of genetically and antigenically diverse virus lineages of subtypes...

    Vanessa Haach, Ana Paula Almeida Bastos, ... Rejane Schaefer in Virology Journal
    Article Open access 16 August 2023
  13. Immunological profile of mice immunized with a polyvalent virosome-based influenza vaccine

    Background

    Influenza A virus (IAV) causes respiratory disease in pigs and is a major concern for public health. Vaccination of pigs is the most...

    Francisco NoƩ Fonseca, Vanessa Haach, ... Ana Paula Bastos in Virology Journal
    Article Open access 21 August 2023
  14. DYNAMIC cohort study evaluating metabolic predictors of influenza vaccine immune response in older adults

    Immunosenescence (age-related immune dysfunction) and inflamm-aging contribute to suboptimal immune responses in older adults to standard-dose...

    Sapna P. Sadarangani, Barnaby E. Young, ... Angela Chow in npj Vaccines
    Article Open access 01 November 2022
  15. Nanoparticle display of neuraminidase elicits enhanced antibody responses and protection against influenza A virus challenge

    Current Influenza virus vaccines primarily induce antibody responses against variable epitopes in hemagglutinin (HA), necessitating frequent updates....

    M. N. Pascha, M. Ballegeer, ... C. A. M. de Haan in npj Vaccines
    Article Open access 31 May 2024
  16. Influenza virus infection history shapes antibody responses to influenza vaccination

    Studies of successive vaccination suggest that immunological memory against past influenza viruses may limit responses to vaccines containing current...

    Maria Auladell, Hoang Vu Mai Phuong, ... Annette Fox in Nature Medicine
    Article 17 February 2022
  17. Self-amplifying mRNA seasonal influenza vaccines elicit mouse neutralizing antibody and cell-mediated immunity and protect ferrets

    Currently licensed influenza vaccines focus immune responses on viral hemagglutinin (HA), while the other major surface glycoprotein neuraminidase...

    Michael Cheung, Cheng Chang, ... Yingxia Wen in npj Vaccines
    Article Open access 04 October 2023
  18. Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine

    Although licensed vaccines against influenza virus have been successful in reducing pathogen-mediated disease, they have been less effective at...

    Cameron Bissett, Sandra Belij-Rammerstorfer, ... Teresa Lambe in npj Vaccines
    Article Open access 26 June 2024
  19. Anti-Influenza Activity of Cetraria islandica Lichen Extracts in In Vitro Experiments

    The toxicity and antiviral activity of extracts obtained by the methods of aqueous and ethanol extraction of bioactive substances from Cetraria...

    E. V. Makarevich, E. I. Filippova, ... N. A. Mazurkova in Bulletin of Experimental Biology and Medicine
    Article 01 June 2023
Did you find what you were looking for? Share feedback.